- Stocks Telegraph Morning
- Posts
- 09 Mar - NH - Morning Newsletter (with survey at top and bottom)
09 Mar - NH - Morning Newsletter (with survey at top and bottom)
The Morning Stock Market Update: Hot Stocks to Watch
The Newsheater daily morning newsletter is powered by Stocks Telegraph
Help us improve newsletter by taking
Good Morning!Based on the trading data, the futures for US stock indices went down on Thursday. On Thursday and Friday, market participants expect to hear about the US labor market.Futures for the Dow Jones Industrial Index (DJIA) decreased by 0.12%, to 32,772 points. NASDAQ high-tech futures surged by 0.52% to 12,165.25 points, and S&P 500 futures climbed 0.26% to 3,984.5 points.Later on Thursday, statistics on the number of initial jobless claims in the US will be published. Analysts predict that in the week to March 4, their number increased by five thousand, to 195 thousand applications.On Friday, the country's unemployment statistics will be released. Experts predict that the unemployment rate in February will remain at the level of January at 3.4%, and the number of jobs in non-agricultural sectors of the economy will increase by 205 thousand after an increase of 517 thousand a month earlier.
My #1 EV Stock (NOT Tesla)
I believe this little-known company will be the next EV giant. Its car is faster than Ferrari's F8, McLaren's 720S and Porsche's 911 Turbo. Yet it's 100% electric. Simply put, this company could be on the verge of a HUGE run.
Sponsored
Today Top Movers
Avenue Therapeutics Inc. (ATXI) stock soared 25.96% to $1.31 in the pre-market trading. The company provided regulatory update on IV Tramadol and other corporate updates.
Asana Inc. (NYSE: ASAN) shares are trading up 22.3% at $21.77 at the time of writing following the release of fourth quarter and fiscal year 2023 revenues.
Clene Inc. (CLNN) grew over 16.92% at $1.52 in pre-market trading today after announcing new results from exploratory analyses including delayed time to key clinical progression events in people living with amyotrophic lateral sclerosis (ALS).
Biophytis S.A. (BPTS), a Biotechnology company, rose about 41.9% at $0.7095 in pre-market trading Thursday after announcing that it presents the positive results of the phase 2-3 COVA study with Sarconeos (BIO101) in severe COVID-19 at the European Respiratory Society 2023 21st Lung Science Conference taking place in Estoril, Portugal, between the 9th and the 12th of March 2023.
Free Report: The Secret Backdoor to OpenAI and ChatGPT
Discover the top 3 hidden AI stocks that could hand you profits of 874% of more!
ChatGPT is the fastest growing app EVER – hitting 100 million users!
Jeff Bezos… Bill Gates… and Elon Musk are betting billions on this "game changing" technology. And you can get in on the ground floor.
Sponsored
Top Upgrades & Downgrades
Citigroup turned bullish on Exact Sciences Corporation (EXAS), upgrading the stock to Buy and assigning a $90 price target, representing potential upside of 38.46% from Wednesday's close.
Hilton Worldwide Holdings Inc. (HLT) has won the favor of Barclays's equity research team. The firm upgraded the shares from Equal-Weight to Overweight and moved their price target to $168, suggesting 13.94% additional upside for the stock.
Vertex Inc. (VERX) received an upgrade from analysts at B of A Securities, who also set their one-year price target on the stock to $20. They changed their rating on VERX to Neutral from Underperform in a recently issued research note.
Earlier Thursday Citigroup reduced its rating on Guardant Health Inc. (GH) stock to Neutral from Buy and assigned the price target to $33.
Jefferies analysts reduced their investment ratings, saying in research reports covered by the media that its rating for TCR2 Therapeutics Inc. (TCRR) has been changed to Underperform from Buy and the new price target is set at $3.
Analysts at Jefferies downgraded Etsy Inc. (ETSY)'s stock to Underperform from Buy Thursday.
5 Stocks Set to Soar in 2023
Eric Fry just released the names of 5 stocks he believes every investor should own, even in these crazy markets — one stock is trading for under $5 .
Sponsored
Latest Insider Activity
Velo3D Inc. (VLD) Director Walters Matthew Joseph announced the sale of shares taking place on Mar 06 at $3.14 for some 10,000 shares. The total came to more than $31412.0.
QuantumScape Corporation (QS) Chief Executive Officer Singh Jagdeep sold on Mar 08 a total 355,000 shares at $7.78 on average. The insider’s sale generated proceeds of almost $2.76 million.
Summit Therapeutics Inc. (SMMT) Co-Chief Executive Officer Zanganeh Mahkam declared the purchase of shares taking place on Mar 08 at $1.05 for some 15,973,743 shares. The transaction amount was around $16.77 million.
Grocery Outlet Holding Corp. (GO) Director Ragatz Erik D. bought on Mar 07 a total 20,000 shares at $27.25 on average. The purchase cost the insider an estimated $545,000.
Free ebook: Learn the 6 Stock Market Myths
Learn the 6 greatest stock market myths – 3 rules to pick the right stocks – Powerful techniques to accurately value stocks – Insights on stock valuation and stock market cycles – Secrets revealed on how to successfully manage your portfolio and much more…
Sponsored
Important Earnings
Top US earnings releases scheduled for today include FuelCell Energy Inc. (NASDAQ: FCEL). It will announce its Jan 2023 financial results. The company is expected to report earnings of -$0.07 per share from revenues of $28.11M in the three-month period.
Analysts expect Arhaus Inc. (NASDAQ: ARHS) to report a net income (adjusted) of $0.2 per share, when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Dec 2022 is predicted to come in at $348.25M.
Akebia Therapeutics Inc. (AKBA), due to announce earnings before the market opens today, is expected to report earnings of -$0.19 per share from revenues of $47.4M recently concluded three-month period.
That's it for today. Thanks for reading. Good luck out there!Best Regards,Stocks Telegraph Team
P.S. Want my daily watchlists sent to your cell phone too? Just go HERE and join my text message list!
Wouldn’t it be great to have a personalized solution for your investing needs? We’re adding new sections to the morning newsletter with big implications. All you have to do is share your thought about the current newsletter. If you do that, we’ll do our best to take your feedback and make it a better experience for you.
We are asking for 1 minute of your time to answer 4 questions about your experience with our newsletter. We hope to use this information to create solutions that address exactly what you need!
Thank you for your continued support.
Disclaimer: Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails.